Cargando…
Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
AIM: To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma (HCC) patients after liver transplant. METHODS: BALAD score and BALAD-2 class are derived from bilirubin, albumin, alpha-fetoprotein (AFP), Lens culinaris agglutinin-reac...
Autores principales: | Wongjarupong, Nicha, Negron-Ocasio, Gabriela M, Chaiteerakij, Roongruedee, Addissie, Benyam D, Mohamed, Essa A, Mara, Kristin C, Harmsen, William S, Theobald, J Paul, Peters, Brian E, Balsanek, Joseph G, Ward, Melissa M, Giama, Nasra H, Venkatesh, Sudhakar K, Harnois, Denise M, Charlton, Michael R, Yamada, Hiroyuki, Algeciras-Schimnich, Alicia, Snyder, Melissa R, Therneau, Terry M, Roberts, Lewis R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871827/ https://www.ncbi.nlm.nih.gov/pubmed/29599607 http://dx.doi.org/10.3748/wjg.v24.i12.1321 |
Ejemplares similares
-
Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis
por: Yongpisarn, Tanat, et al.
Publicado: (2021) -
Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation
por: Zhang, Ning, et al.
Publicado: (2018) -
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
por: Wongjarupong, Nicha, et al.
Publicado: (2017) -
Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma
por: Chaiteerakij, Roongruedee, et al.
Publicado: (2015) -
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
por: Fox, R, et al.
Publicado: (2014)